Kimelman & Baird, LLC Abbott Laboratories Transaction History
Kimelman & Baird, LLC
- $1.21 Trillion
- Q2 2024
A detailed history of Kimelman & Baird, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Kimelman & Baird, LLC holds 29,939 shares of ABT stock, worth $3.45 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
29,939
Previous 20,300
47.48%
Holding current value
$3.45 Million
Previous $2.35 Million
132112.58%
% of portfolio
0.26%
Previous 0.21%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,177Shares Held
1.33BCall Options Held
8.62MPut Options Held
7.18M-
Vanguard Group Inc Valley Forge, PA166MShares$19.2 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.58 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.28 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.6 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $202B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...